These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 15019326)

  • 1. Evaluation of patients with scleritis for systemic disease.
    Akpek EK; Thorne JE; Qazi FA; Do DV; Jabs DA
    Ophthalmology; 2004 Mar; 111(3):501-6. PubMed ID: 15019326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis.
    Lin P; Bhullar SS; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2008 Mar; 145(3):463-471. PubMed ID: 18061135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases.
    Gonzalez-Gonzalez LA; Molina-Prat N; Doctor P; Tauber J; Sainz de la Maza MT; Foster CS
    Ophthalmology; 2012 Jul; 119(7):1460-4. PubMed ID: 22463821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleritis: a clinicopathologic study of 55 cases.
    Riono WP; Hidayat AA; Rao NA
    Ophthalmology; 1999 Jul; 106(7):1328-33. PubMed ID: 10406616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status.
    Comfere NI; Macaron NC; Gibson LE
    J Cutan Pathol; 2007 Oct; 34(10):739-47. PubMed ID: 17880578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
    Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I
    Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L; Savage CO
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lethal complications and associated diseases of rheumatoid arthritis--a retrospective clinicopathologic study of 234 autopsy patients].
    Bély M; Apáthy A
    Orv Hetil; 2006 Jun; 147(23):1063-76. PubMed ID: 16856508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of episcleritis and systemic disease association.
    Akpek EK; Uy HS; Christen W; Gurdal C; Foster CS
    Ophthalmology; 1999 Apr; 106(4):729-31. PubMed ID: 10201593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
    Ye H; Gao Y; Guo XH; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3323-7. PubMed ID: 16409836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleritis therapy.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.
    Yu F; Chen M; Gao Y; Wang SX; Zou WZ; Zhao MH; Wang HY
    Am J Kidney Dis; 2007 May; 49(5):607-14. PubMed ID: 17472842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
    Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: A long-term followup study.
    Slot MC; Links TP; Stegeman CA; Tervaert JW
    Arthritis Rheum; 2005 Feb; 53(1):108-13. PubMed ID: 15696557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy is increased in ANCA-associated vasculitis.
    Pankhurst T; Savage CO; Gordon C; Harper L
    Rheumatology (Oxford); 2004 Dec; 43(12):1532-5. PubMed ID: 15316126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
    Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
    Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learnt in the management of Wegener's Granulomatosis: long-term follow-up of 60 patients.
    Sproson EL; Jones NS; Al-Deiri M; Lanyon P
    Rhinology; 2007 Mar; 45(1):63-7. PubMed ID: 17432073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mononeuritis multiplex: the yield of evaluations for occult rheumatic diseases.
    Hellmann DB; Laing TJ; Petri M; Whiting-O'Keefe Q; Parry GJ
    Medicine (Baltimore); 1988 May; 67(3):145-53. PubMed ID: 2835572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.